Although life science company boards are recruiting more women, a lack of managing their talent during their career is slowing the progress towards greater diversity, according to life sciences human resources specialist RSA’s biannual survey of non-executive directors. 14 October 2014
Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the board of directors, replacing Anders Wiklund. 14 October 2014
Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president and head of development for the company’s global vaccine business unit. 8 October 2014
Canadian biopharmaceutical company Aeterna Zentaris has named Philip Theodore as senior vice president, chief administrative officer, general counsel and corporate secretary. 7 October 2014
Satish Jindal has been appointed to lead the discovery of drug candidates from leading academic institutions at Allied-Bristol Life Sciences, a jointly-owned enterprise between Allied Minds and US drug major Bristol-Myers Squibb. 6 October 2014
US-based clinical biopharmaceutical company Mast Therapeutics has named Edwin Parsley, has joined the company as its chief medical officer and senior vice president. 2 October 2014
USA-based specialty pharmaceutical company Zynerba Pharmaceuticals, focused on innovative transdermal cannabinoid treatments, has named two leading industry veterans to lead the company. 2 October 2014
Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief executive on an interim basis, following the departure of Torbjörn Bjerke from the position. 30 September 2014
Oncology drug development company focused on antibody drug conjugates targeting major cancers, ADC Therapeutics, has expanded its team significantly as the company’s first antibody drug conjugates enter clinical development. 30 September 2014
UK respiratory specialist Verona Pharma has appointed Biresh Roy as chief financial officer and member of the board of directors, taking over from Richard Bungay. 30 September 2014
Israeli pharma company Protalix BioTherapeutics has appointed Moshe Manor as its new president and chief executive, effective from November 2. 29 September 2014
UK pharma giant GlaxoSmithKline this morning confirmed recent rumors, saying that Sir Philip Hampton will join the company’s board as non-executive director from January 1, 2015, and will become deputy chairman with effect from April 1, 2015. 25 September 2014
Inflammation, oncology and biodefense biopharma company Soligenix has announced the appointment of Rasappa Arumugham as vice president of biopharmaceutical development. 23 September 2014
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024